{
    "links": "https://www.ycombinator.com/companies/intact-therapeutics",
    "name": "Intact Therapeutics",
    "headline": "Smart gels for local drug delivery to the gut",
    "batch": "W19",
    "description": "Intatct is developing an advanced materials platform to improve the way drugs are delivered and absorbed in the digestive tract. Our vision is to improve the treatment of a wide range of gastrointestinal disorders that are currently underserved.",
    "activity_status": "Active",
    "website": "http://www.intacttherapeutics.com",
    "founded_date": 2015.0,
    "team_size": 4.0,
    "location": "Palo Alto",
    "group_partner": null,
    "group_partner_yc": null,
    "company_linkedin": null,
    "company_twitter": null,
    "tags": "industry:drug-delivery; industry:therapeutics; location:san-francisco-bay-area",
    "founders": [
        {
            "name": "Ravi Pamnani, Founder/CEO",
            "description": "Passionate about intersection of health and technology.",
            "linkedin": "https://www.linkedin.com/in/rpamnani/"
        },
        {
            "name": "Sidhartha Sinha, Founder",
            "description": null,
            "linkedin": "https://www.linkedin.com/in/sidhartha-sinha-47277125/"
        }
    ],
    "status": true,
    "generated_description": "## Intact Therapeutics: Revolutionizing Drug Delivery for Gut Health\n\n### Overview\nFounded in 2015 and based in Palo Alto, California, **Intact Therapeutics** is an innovative biotech company focused on developing a platform of **smart gels** designed for localized drug delivery specifically to the gut. This initiative aims to tackle a variety of gastrointestinal disorders that are often under-treated, utilizing advanced materials to enhance how drugs are delivered and absorbed.\n\n### Mission\nThe company's mission is straightforward: **\"Smart gels for local drug delivery to the gut.\"** This encapsulates their commitment to leveraging technology that meets the specific needs of patients suffering from gastrointestinal issues, ultimately improving their treatment outcomes.\n\n### Team and Background\nIntact Therapeutics started out as \"Intatct\" and has grown into a lean team of just **four employees.** They are part of the esteemed **Y Combinator Batch W19,** which has provided them with the necessary mentorship and resources to refine their innovations. The company partners with notable organizations, including **Nan** as a Group Partner, indicating a strong network of industry connections.\n\n### Current Endeavors\nThe company is actively involved in research and development, honing in on their cutting-edge smart gel technology. This approach not only holds promise for better drug efficiency but also attempts to improve patient experiences by targeting medications more directly where they are needed.\n\n### Tags and Associations\nIntact Therapeutics fits within critical domains like **drug delivery** and **therapeutics**, with specific relevance in the **San Francisco Bay Area**, a hub for biotech innovation. \n\n### Online Presence\nFor more detailed information, project updates, and insights into their journey, check out their website: [Intact Therapeutics](http://www.intacttherapeutics.com).\n\n### Conclusion\nIn sum, Intact Therapeutics embodies the spirit of biotech innovation by addressing critical yet underserved needs in gut health. With their unique approach to drug delivery through smart gels, they are not just another startup\u2014they're potential trailblazers in gastrointestinal therapeutics. Keep an eye on them; they could very well change the landscape of treatment for gastrointestinal disorders.",
    "logo": "https://bookface-images.s3.us-west-2.amazonaws.com/logos/394369f3ac5b2ae76404166d7d3eb21d185e82aa.png?X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=ASIAQC4NIECAEHIR6H6F%2F20250221%2Fus-west-2%2Fs3%2Faws4_request&X-Amz-Date=20250221T191436Z&X-Amz-Expires=3600&X-Amz-Security-Token=IQoJb3JpZ2luX2VjELP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCXVzLXdlc3QtMiJIMEYCIQDt736ZW5EfzagAz1eKRSs%2FW4TfHu28RBSFaRNkZ9h47gIhANt6WXtwkgL07bQKDKYDGFxYKx7WOO9JX0BqaYrXnKNbKu4DCNz%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEQABoMMDA2MjAxODExMDcyIgx8TqkMwTM2PLcRmr4qwgPGGtQBXv7gs7%2BXGteI1gQk%2FjkbIHwQ5hCKXJKVmVAPw3MeVLhZyp8Nf5%2FYigbwE%2BrFR7aZWKjrs7HxAE0JWit5dlINZLjZK%2BS%2FwMaCqoj%2BFDN0gw9iiAPu4Xn5c3b%2BuZe%2F5%2Flfk0EuxZAXVsZtShxXZy%2FERPQ0v%2FRZxSz5qUoaXpL1zj6VWdWVzoI7%2FPlB3bgJ2PpiF7DN%2BJeDsJPx%2FoKTo5ehP9pOeGbMNxoeegVJsCJ3zvzO3o4fcZYIf6c5iIJwM1Ot3Gg7Z3v9oLZjSRU%2FaRLL5j4n3II7DaroOCEVfPlWzTyZM7SNFZZAFSKM8vLKj1VdTr9s3How41zluf%2FOIp7sGNhG%2FjuYJoG%2FmkLFIlYP4wbGrLO69AWnenZyfi1UhAiV6N%2BlAqGnqvpOJh4vq8uNh2eRnXR%2BMVXdq9oVYkm7XFgprL5PDC4ULLyBWqA6kca4z7F4H56nkT%2FsDtT8ek2VOIRIv1Zgcz%2BeeVG7F7AHS4bdbR6eZ3ChY1iQhfPBErh4OiFQM7IqiUKw%2B1CTpvL68xcVN5gjiaDH0Jotw%2BUcW9dMSg9py8xH8qgyiWG5w3dDj9xaoA2G3NMYq6JOGKMwwIrjvQY6pAHDH54nhADhmb7YSEGxHkL3pqs%2B6aYOExStWbzLKzRb3lb2DAgGG8uU9COt8%2FqUEOtOcszTKp7yuCJwMVkfI7PDZ74h9uiRkRxjtH7%2BLlE1xrfd%2FrIq%2B%2BZr9hSFqZ9MUQ4yNHesyx2FYDbsIfCW9ntlrpmZUHCcrzpQDfufsAFcpe%2FudVT3tUqiF8WCN1Vd%2Bx%2FQ9d3i1HvBcJWV9AYAwM0W22VM%2BA%3D%3D&X-Amz-SignedHeaders=host&X-Amz-Signature=2a4702cd85188ead385f1d1dd6df2bf529d7b408c2b56e0c7fd4675405fa13d4",
    "social_links": [
        "https://www.linkedin.com/company/intact-therapeutics",
        "https://www.crunchbase.com/organization/intact-therapeutics"
    ],
    "logo_path": "data/logos\\Intact_Therapeutics_logo.png"
}